Renovo Group plc announced positive results in a clinical trial designed to establish the safety and efficacy of a new formulation of the scar revision drug Juvista intended for use in children.
Vertex Pharmaceuticals Incorporated has completed the submission of a new drug application to the U.S. Food and Drug Administration seeking approval for telaprevir, Vertex's investigational treatment for people with hepatitis C.
Dual antiplatelet therapy—treatment with the medications clopidogrel and aspirin together to prevent blood clots—poses a clinically significant risk of hemorrhage that should be considered before prescribing.
New findings by civil engineering researchers show that treating municipal wastewater solids at higher temperatures may be an effective tool in the fight against antibiotic-resistant bacteria.
The same powerful drugs that have extended the lives of countless people with HIV come with a price – insulin resistance that can lead to diabetes and cardiovascular disease.
Both the rate and direction of axon growth in the spinal cord can be controlled. A series of connections at the cellular level produce a guidance cue that tells an axon how fast and in which direction to grow in an embryonic environment.
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease that eventually destroys most motor neurons, causing muscle weakness and atrophy throughout the body. There is no cure and the current treatment has only a moderate effect on the disease.
HIV infected patients whose treatment is delayed not only become sicker than those treated earlier, but also require tens of thousands of dollars more in care over the first several years of their treatment.
Most patients who take anti-depressants give up their treatment in less than six months, the minimum period recommended for treating severe depression and only 25% continue their treatment for more than 11 months.
Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor is the size of a quarter and can detect viruses in a blood sample.
Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy.
Reinnervate has announced the first commercial launch of alvetex, its 3D cell culture technology. Alvetex provides a robust and inert scaffold for cells to grow and form complex 3D cell structures, mimicking the normal growth and formation of tissues.
Thermo Fisher Scientific Inc. has introduced the ThermoChill I and ThermoChill II re-circulating chillers. These compact, floor-standing re-circulating chillers provide a temperature range of 5 to 30°C and have a cooling capacity from 700 to 2000 W.
Researchers at Harvard Medical School and the Harvard School of Dental Medicine have found that by mimicking a rare genetic disorder in a dish, they can rewind the internal clock of a mature cell and drive it back into an adult stem-cell stage.
Researchers have successfully transformed normal human tissue into three-dimensional cancers in a tissue culture dish for the first time. Watching how the cells behave as they divide and invade surrounding tissue will help physicians better understand how human cancers act in the body.